Send to

Choose Destination
J Invest Dermatol. 2014 May;134(5):1408-1417. doi: 10.1038/jid.2013.509. Epub 2013 Nov 27.

Protein oxidation and DNA repair inhibition by 6-thioguanine and UVA radiation.

Author information

Cancer Research UK London Research Institute, Clare Hall Laboratories, South Mimms, Herts, UK.
Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/Inserm/ULP, BP163, Strasbourg, France.
Cancer Research UK London Research Institute, Clare Hall Laboratories, South Mimms, Herts, UK. Electronic address:


Damage to skin DNA by solar UV is largely unavoidable, and an optimal cellular response to it requires the coordinated operation of proteins in numerous pathways. A fully functional DNA repair proteome for removing harmful DNA lesions is a prerequisite for an appropriate DNA damage response. Genetically determined failure to repair UV-induced DNA damage is associated with skin photosensitivity and increased skin cancer risk. Patients treated with immunosuppressant/anti-inflammatory thiopurines are also photosensitive and have high rates of sun-related skin cancer. Their DNA contains the base analog 6-thioguanine (6-TG), which acts as a UVA photosensitizer to generate reactive oxygen species (ROS), predominantly singlet oxygen ((1)O2). ROS damage both DNA and proteins. Here we show that UVA irradiation of cultured human cells containing DNA 6-TG causes significant protein oxidation and damages components of the DNA repair proteome, including the Ku, OGG-1, MYH, and RPA proteins. Assays of DNA repair in intact cells or in cell extracts indicate that this protein damage compromises DNA break rejoining and base and nucleotide excision repair. As these experimental conditions simulate those in the skin of patients taking thiopurines, our findings suggest a mechanism whereby UVA in sunlight may contribute to skin carcinogenesis in immunosuppressed patients.

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center